Stay updated on MRD-Guided Treatment in NPM1mut AML Clinical Trial

Sign up to get notified when there's something new on the MRD-Guided Treatment in NPM1mut AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRD-Guided Treatment in NPM1mut AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.8%
    Check dated 2025-05-01T03:51:40.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-04-23T19:00:36.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a clinical trial evaluating the safety and efficacy of Pembrolizumab in combination with Azacitidine for AML patients, and the addition of collaborators and a revision number.
    Difference
    46%
    Check dated 2025-04-16T14:22:40.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T09:17:25.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:20:02.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-25T14:00:49.000Z thumbnail image

Stay in the know with updates to MRD-Guided Treatment in NPM1mut AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRD-Guided Treatment in NPM1mut AML Clinical Trial page.